Mr. Jiawei Zheng | Toxicology | Excellence in Research Award
Jinquan Satellite Launch Center Hospital | China
Jiawei Zheng is an attending doctor at the Jiuquan Satellite Launch Center Hospital whose work integrates clinical practice with specialized research in occupational toxicology, particularly focusing on hepatotoxicity mechanisms relevant to aerospace environments. Trained in medical sciences with a concentration in toxicology, he has built a career that blends laboratory investigation with applied aerospace-medicine service, serving as a principal investigator for internally supported projects aimed at understanding and mitigating toxin-induced organ injury. His research explores oxidative stress, apoptosis signaling, and metabolic intervention, with special emphasis on the pathways disrupted by exposure to aerospace-related chemicals. He has developed strong skills in experimental design, animal modeling, cellular and biochemical analysis, mechanistic interpretation, and scientific writing, demonstrated through his first-author contribution to a peer-reviewed article that reveals a novel mechanistic pathway underlying UDMH-induced liver injury. His professional experience also includes leading a hospital consultancy initiative focused on toxicological risk assessment. Although early in his publication journey, his work has already contributed meaningful insights to the field of hepatotoxicity research. With dedication to advancing occupational health protection for aerospace personnel, he continues to pursue research that supports scientific innovation, clinical safety, and the broader mission of improving health resilience in high-risk technological environments.
Profile: ORCID
Featured Publications
Zheng, J., Liu, W., Zhu, X., Ran, L., Lang, H., Yi, L., Mi, M., & Zhu, J. (2020). Pterostilbene enhances endurance capacity via promoting skeletal muscle adaptations to exercise training in rats. Molecules, 25(1), 186.
Huang, Y., Zhu, X., Chen, K., Lang, H., Zhang, Y., Hou, P., Ran, L., Zhou, M., Zheng, J., Yi, L., & Mi, M. (2019). Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway. Aging (Albany NY), 11(8), 2217–2240.